iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Shares Sold by American Research & Management Co.

American Research & Management Co. reduced its position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 6.2% during the first quarter, Holdings Channel.com reports. The fund owned 2,185 shares of the financial services provider’s stock after selling 145 shares during the quarter. American Research & Management Co.’s holdings in iShares Nasdaq Biotechnology ETF were worth $329,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in IBB. First Trust Advisors LP grew its holdings in iShares Nasdaq Biotechnology ETF by 69.0% during the first quarter. First Trust Advisors LP now owns 16,417 shares of the financial services provider’s stock worth $1,835,000 after acquiring an additional 6,701 shares during the period. Eudaimonia Partners LLC increased its stake in iShares Nasdaq Biotechnology ETF by 2,566.8% in the 3rd quarter. Eudaimonia Partners LLC now owns 27,255 shares of the financial services provider’s stock worth $494,000 after purchasing an additional 26,233 shares in the last quarter. Intrua Financial LLC purchased a new position in iShares Nasdaq Biotechnology ETF in the 3rd quarter worth about $206,000. Stumpf Capital Management LLC purchased a new position in iShares Nasdaq Biotechnology ETF in the 3rd quarter worth about $34,000. Finally, Alhambra Investment Partners LLC purchased a new position in iShares Nasdaq Biotechnology ETF in the 3rd quarter worth about $379,000. 79.80% of the stock is currently owned by hedge funds and other institutional investors.

IBB traded up $1.16 during trading on Thursday, reaching $150.01. The company had a trading volume of 51,272 shares, compared to its average volume of 3,333,646. The firm’s 50-day simple moving average is $154.90 and its 200 day simple moving average is $152.85. iShares Nasdaq Biotechnology ETF has a 12-month low of $109.36 and a 12-month high of $174.04.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: What is range trading?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.